Bloomberg Technology
Ginkgo Bioworks CEO: Delta Will Be ‘Endemic Like the Flu’
Sep.17 — Ginkgo Bioworks CEO Jason Kelly speaks with Emily Chang about their historic SPAC close, charting the next step for the pandemic, and how Ginkgo’s ramped up testing for schools nationwide.
Sir Derty ✓
September 17, 2021 at 11:12 pm
spac’s are fishy
Sir Derty ✓
September 17, 2021 at 11:15 pm
Oh look, another elizabeth holmes…
He learned how to talk to tell you what you want.. he is a good salesman, for sure, but smart people can see through the smoke and mirrors.
….wow, no Jason.. This guy talking about my industry cannabis and its old news.. he did not invent yeast with THC, he is just saying things people want to buy into (401K grower for canopy growth here, he doesnt know half what I know)
This guy reminds me of that Elizabeth girl from
Santiago Aguado Russo
September 19, 2021 at 10:19 am
Completely disagree. They have proven their technology works on several applications.
Lupus
September 19, 2021 at 9:02 pm
@Santiago Aguado Russo not only several occasions, literally scaling faster than anybody else and making a multitude of revolutionary products possible. if they were a theranos type of scam they wouldn’t be gaining customers faster they can execute.
Sophie Morris
September 17, 2021 at 11:39 pm
var.fyi
smashing
Matt Markey
September 17, 2021 at 11:55 pm
Awesome work Jason! I can’t wait to look back at your body of work years from now.
golgothan
September 18, 2021 at 2:18 pm
Can’t wait.
Santiago Aguado Russo
September 19, 2021 at 10:18 am
The market cap is wrong…🤦🏼
It was 15bn plus the 2.4bn in cash, so 17,4bn when it went public at $10 per share.